PRP Injections & Treatment Systems in Salt Lake City, UT

What I’d check before adding prp injections here

Salt Lake City is a city under 250k (200,133 Census). CDC PLACES (2023, crude) estimates 7.9% of adults in Salt Lake City have diagnosed diabetes — 4.1 points below the U.S. 12% figure. Adult arthritis here is 18.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.

Epidemiology is not a protocol

• Adult arthritis here is 18.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 12.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in Utah.
• Utah is outside CDC's historical Diabetes Belt core, but the national 12% diabetes figure still applies as a planning baseline until a clinic uses its own payer mix. Clinics asking for regenerative inventory still have to separate HCT/P 361 homologous-use products from unapproved “stem cell” claims (FDA 21 CFR 1271).
• Population 200,133 (Census city proper) understates metro demand and overstates how many of those people will ever see a biologic. Use it as scale, then underwrite against clinic specialty mix.

Payer geography for Salt Lake City, UT

JF reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Salt Lake City is 7.9% or not. PLACES is planning data. The LCD is the claim.

How we’d stand this up in clinic